Congress Asset Management Co. Sells 89,308 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Congress Asset Management Co. decreased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 7.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,157,876 shares of the medical device company’s stock after selling 89,308 shares during the quarter. Congress Asset Management Co. owned about 0.58% of Cooper Companies worth $106,444,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Victory Capital Management Inc. raised its holdings in Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares during the last quarter. Highland Capital Management LLC bought a new position in Cooper Companies during the 4th quarter worth approximately $4,004,000. Franklin Resources Inc. raised its holdings in Cooper Companies by 194.0% during the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock worth $5,265,000 after purchasing an additional 32,260 shares during the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in Cooper Companies during the 4th quarter worth approximately $691,000. Finally, Principal Financial Group Inc. raised its holdings in Cooper Companies by 6.6% during the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock worth $26,295,000 after purchasing an additional 14,687 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

COO opened at $88.10 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market capitalization of $17.58 billion, a price-to-earnings ratio of 45.18, a P/E/G ratio of 2.41 and a beta of 1.00. The firm’s fifty day moving average price is $93.94 and its two-hundred day moving average price is $99.78. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.87 EPS. As a group, analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

COO has been the subject of several research analyst reports. Morgan Stanley lowered their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Wells Fargo & Company lifted their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Citigroup lowered their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Finally, StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.